Severe covid-19 pneumonia: pathogenesis and clinical management

AH Attaway, RG Scheraga, A Bhimraj, M Biehl… - bmj, 2021 - bmj.com
Severe covid-19 pneumonia has posed critical challenges for the research and medical
communities. Older age, male sex, and comorbidities increase the risk for severe disease …

[HTML][HTML] The Japanese clinical practice guidelines for management of sepsis and septic shock 2020 (J-SSCG 2020)

M Egi, H Ogura, T Yatabe, K Atagi, S Inoue, T Iba… - Journal of intensive …, 2021 - Springer
Abstract The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic
Shock 2020 (J-SSCG 2020), a Japanese-specific set of clinical practice guidelines for sepsis …

An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy

O Roca, B Caralt, J Messika, M Samper… - American journal of …, 2019 - atsjournals.org
Rationale: One important concern during high-flow nasal cannula (HFNC) therapy in
patients with acute hypoxemic respiratory failure is to not delay intubation. Objectives: To …

[HTML][HTML] Use of nasal high flow oxygen during acute respiratory failure

JD Ricard, O Roca, V Lemiale, A Corley… - Intensive care …, 2020 - Springer
Nasal high flow (NHF) has gained popularity among intensivists to manage patients with
acute respiratory failure. An important literature has accompanied this evolution. In this …

Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure

B Rochwerg, L Brochard, MW Elliott… - European …, 2017 - Eur Respiratory Soc
Noninvasive mechanical ventilation (NIV) is widely used in the acute care setting for acute
respiratory failure (ARF) across a variety of aetiologies. This document provides European …

Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks

DS Hui, BK Chow, T Lo, OTY Tsang… - European …, 2019 - Eur Respiratory Soc
Background High-flow nasal cannula (HFNC) is an emerging therapy for respiratory failure
but the extent of exhaled air dispersion during treatment is unknown. We examined exhaled …

Effect of high-flow nasal oxygen vs standard oxygen on 28-day mortality in immunocompromised patients with acute respiratory failure: the HIGH randomized clinical …

E Azoulay, V Lemiale, D Mokart, S Nseir, L Argaud… - Jama, 2018 - jamanetwork.com
Importance High-flow nasal oxygen therapy is increasingly used for acute hypoxemic
respiratory failure (AHRF). Objective To determine whether high-flow oxygen therapy …

Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study

E Azoulay, P Pickkers, M Soares, A Perner, J Rello… - Intensive care …, 2017 - Springer
Background In immunocompromised patients with acute hypoxemic respiratory failure
(ARF), initial management aims primarily to avoid invasive mechanical ventilation (IMV) …

[HTML][HTML] Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party …

M Kochanek, E Schalk, M von Bergwelt-Baildon… - Annals of …, 2019 - Springer
Sepsis and septic shock are major causes of mortality during chemotherapy-induced
neutropenia for malignancies requiring urgent treatment. Thus, awareness of the presenting …

High-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: a randomised …

R Coudroy, JP Frat, S Ehrmann, F Pene… - The Lancet …, 2022 - thelancet.com
Background Although non-invasive ventilation (NIV) is recommended for
immunocompromised patients with acute respiratory failure in the intensive care unit (ICU), it …